Centiva Capital »

Inhibrx Biosciences shares owned by Centiva Capital

Quarter-by-quarter ownership of Inhibrx Biosciences (INBX) shares owned by Centiva Capital from 13F filings

Historical chart of Centiva Capital investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by Centiva Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by Centiva Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.2M 18k 67.23

More positions owned by Centiva Capital

NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Tesla Motors (TSLA)
Apple (AAPL)
Netflix (NFLX)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Alphabet Cap Stk Cl C (GOOG)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Ishares Tr China Lg-cap Etf (FXI)
Ishares Silver Tr Ishares Call Option (SLV)
Spdr Series Trust State Street Spd (KRE)

View all positions for Centiva Capital

Top funds holding Inhibrx Biosciences

Perceptive Advisors
Viking Global Investors
Morgan Stanley
Sanofi
HighTower Advisors
BlackRock
Susquehanna International
Vanguard Group
Vanguard Capital Management
Caligan Partners
Sofinnova Ventures
Capital Research Global Investors
Woodline Partners
State Street Corporation
Millennium Management

View all funds holding Inhibrx Biosciences